Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma

Published:2022-03-01 Issue:3 Volume:5 Page:e220615
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Beasley Richard¹²³,Harrison Tim⁴⁵,Peterson Stefan⁶,Gustafson Per⁷,Hamblin Angus⁸,Bengtsson Thomas⁶,Fagerås Malin⁷

Affiliation:

1. Medical Research Institute of New Zealand, Wellington, New Zealand

2. Capital and Coast District Health Board, Wellington, New Zealand

3. Victoria University Wellington, Wellington, New Zealand

4. Nottingham National Institute for Health Research Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom

5. Digital Health Research & Development, AstraZeneca, Cambridge, United Kingdom

6. StatMind, Lund, Sweden

7. BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden

8. BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2789512/beasley_2022_oi_220040_1652279467.30871.pdf

Reference19 articles.

1. Association of inhaled corticosteroids and long-acting ß-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis.;Sobieraj;JAMA,2018

2. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.;O’Byrne;Am J Respir Crit Care Med,2005

3. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.;Reddel;Am J Respir Crit Care Med,2009

4. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.;Kuna;Int J Clin Pract,2007

5. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.;Patel;Lancet Respir Med,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Clinical Decision Support Tool to Implement Asthma Management Guidelines in Pediatric Primary Care (Preprint);2024-08-28

2. The Efficacy of Budesonide-formoterol in Patients with Acute Attacks of Mild-to-moderate Bronchial Asthma: An Observational Study;Iranian Journal of Allergy, Asthma and Immunology;2024-08-10

3. Comparison of Budesonide/formoterol versus Fluticasone furoate/vilanterol as maintenance and reliever therapy for asthma control: a real-world observational study;BMC Pulmonary Medicine;2024-08-01

4. Patterns of asthma medication use and hospital discharges in New Zealand;Journal of Allergy and Clinical Immunology: Global;2024-08

5. Effect of aerosol inhalation of budesonide on respiratory symptoms and inflammatory factors in patients with asthma: a meta-analysis;Journal of Asthma;2024-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3